3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
Veristat will be exhibiting at BioEurope Spring 2018 for the first time! We’ve attended this event for the past 2 years but are excited to be at booth #34 this year. Whether you are at this event to seek funding or need to find the right clinical partner to get your trial started, reach out to Veristat.
To speak with Veristat at BioEurope Spring 2018, you may either request a meeting through the conference partnering system or fill out the form on the right hand side of this page. Veristat focuses on supporting start-up and small biotech firms with strategic guidance, clinical and biometrics expertise and regulatory experience to progress your medical therapies through the clinical development & regulatory submission process. We will customize our solutions to help you meet your short and/or long-term goals. Learn more about our services.
Are you looking to start a new trial or bring your current trial to the United States for FDA Approval? We can help you from IND to NDA Approval and anywhere in between. Partner with us for regulatory, statistical or medical consulting, engage our clinical operations and biometrics teams to design and run your trials, and work with our data standards, and medical writing teams to prepare your regulatory submission package.
3 min read
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
3 min read
Apr 24, 2026 Veristat Blog
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...